LP
OCEA

LMR Partners’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

LMR Partners’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,830
Closed -$71.9K – 1157
2023
Q1 		$71.9K Buy
+10,830
New +$91.5K ﹤0.01% 958

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

LMR Partners's OCEA Position: Q2 2023 in Review

LMR Partners sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2023, closing a stake of 10,830 shares — an estimated $71.9K sold.

LMR Partners first reported a position in OCEA in Q1 2023 and held it in 1 quarter. The position peaked at $71.9K in Q1 2023. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2023.

  • LMR Partners reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • LMR Partners sold 10,830 Ocean Biomedical, Inc. Common Stock shares in Q2 2023, an estimated $71.9K.
  • LMR Partners first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • LMR Partners's Ocean Biomedical, Inc. Common Stock position peaked at $71.9K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.